ESTRO 2024 - Abstract Book

S5643

RTT - Patient experience and quality of life

ESTRO 2024

4. van Beek FE, Jansen F, Mak L, Lissenberg-Witte BI, Buter J, Vergeer MR, et al. The course of symptoms of anxiety and depression from time of diagnosis up to 2 years follow-up in head and neck cancer patients treated with primary (chemo)radiation. Oral Oncol, 2020. 102: p. 104576. 5. Beck KR, Tan SM, Lum SS, Lim LE, and Krishna LK. Validation of the emotion thermometers and hospital anxiety and depression scales in Singapore: Screening cancer patients for distress, anxiety and depression. Asia Pac J Clin Oncol, 2016. 12(2): p. e241-9. 6. Akechi T, Okuyama T, Sugawara Y, Nakano T, Shima Y, and Uchitomi Y. Major depression, adjustment disorders, and post-traumatic stress disorder in terminally ill cancer patients: associated and predictive factors. J Clin Oncol, 2004. 22(10): p. 1957-65. 7. Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview based studies. Lancet Oncol, 2011. 12(2): p. 160-74.

8. Chen AM, Daly ME, Vazquez E, Courquin J, Luu Q, Donald PJ, et al. Depression among long-term survivors of head and neck cancer treated with radiation therapy. JAMA Otolaryngol Head Neck Surg, 2013. 139(9): p. 885-9.

9. Linden W, Vodermaier A, Mackenzie R, and Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord, 2012. 141(2-3): p. 343-51.

498

Digital Poster

Improving male patients experience in radiotherapy to the lower limb using a new positioning device.

Rosemary Muk Ting 1 , Elliott Hastings 1 , Shane H Zaidi 2,3 , Aisha B Miah 2,3 , Claire Surji 1 , Mandy Humphreys 1 , Helen Taylor 1 , Helen McNair 1,3 1 Royal Marsden NHS Foundation Trust, Department of Radiotherapy, London, United Kingdom. 2 Royal Marsden NHS Foundation Trust, Sarcoma Unit, Department of Radiotherapy and Physics, London, United Kingdom. 3 Institute of Cancer Research, London, London, United Kingdom

Purpose/Objective:

Background: Sarcoma is a rare cancer that commonly arises in extremities. Patients have a poor survival rate and 90% of patients have suboptimal treatment experience 1-3 . The challenge with radiotherapy is to deliver a tumoricidal dose to the target whilst minimising radiation dose to critical organs or healthy tissues. In the case of male sarcoma cancer patients, the dose to the external genitalia when treating proximal lower limbs (thigh) must be minimised 4,5 . There is a lack of guidelines regarding optimal positioning and immobilisation 4 . Bandages, fabric sheet or paper, spatula, testicular shielding or thermoplastic casts are commonly used to keep the genitalia away from the treatment field. This process is performed by therapeutic radiographers and is often time-consuming involving many adjustments. Patients feedback has suggested the process can be embarrassing and uncomfortable.

Purpose: To improve the patient experience of male patients receiving radiotherapy to the thigh by using a novel immobilisation device “Ting-Sling” for dressing external genitalia away from the radiotherapy beam.